BR1018-1

Boryung Pharmaceutical Co., Ltd · Phase 1 active Small molecule

At a glance

Generic name	BR1018-1
Sponsor	Boryung Pharmaceutical Co., Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BR1018-1 CI brief — competitive landscape report
BR1018-1 updates RSS · CI watch RSS
Boryung Pharmaceutical Co., Ltd portfolio CI